Although Mandrup-Poulsen and the AIDA study group (2013) reported that IL-1 inhibitor treatment is not effective against type 1 diabetes [26], its outcomes in mitigating type 2 diabetes remain to be evaluated. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.